We are live on
!
Find out more
EV
Eclipse Ventures Portfolio holdings
AUM
$2.57B
This Fund
S&P 500
This Quarter
Est. Return
+4.85%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.69M
AUM Growth
-$114M
(-92%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-1,181.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enovix
ENVX
|
+$113M |
| 2 |
LHDX
Lucira Health, Inc. Common Stock
LHDX
|
+$1.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
Similar funds
RFP
PC
MC
TC
CL
CTA
PI
SCA
Eclipse Ventures's Q2 2023 Portfolio in Review
As of Q2 2023, Eclipse Ventures held 3 positions worth $9.69M, down 92% from $124M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Eclipse Ventures withdrew a net $114M in Q2 2023, closing 2 positions. Its most notable exit was Enovix, an estimated $113M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 8.6% a quarter earlier, followed by Industrials.
- Eclipse Ventures fully exited Enovix in Q2 2023, selling an estimated $113M.
- Eclipse Ventures's ten largest holdings make up 100% of its $9.69M portfolio in Q2 2023.
- Eclipse Ventures opened 0 new positions and closed 2 in Q2 2023.
- Eclipse Ventures's portfolio value fell 92% quarter-over-quarter to $9.69M.
Based on Eclipse Ventures's 13F filing for Q2 2023, filed 10 Aug 2023.